Literature DB >> 23531886

Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.

Vural Ozdemir1, Alexander Borda-Rodriguez, Edward S Dove, Lynnette R Ferguson, Farah Huzair, Vangelis G Manolopoulos, Mario Masellis, Djims Milius, Louise Warnich, Sanjeeva Srivastava.   

Abstract

Keywords:  Genomics and development; P5 medicine; STS and organizations; genomics without borders; global governance of biotechnology innovation and uncertainty; public health pharmacogenomics; responsible innovation; theranostic medicine

Year:  2013        PMID： 23531886      PMCID： PMC3606133          DOI： 10.2174/1875692111311010001

Source DB:  PubMed          Journal:  Curr Pharmacogenomics Person Med        ISSN： 1875-6913


× No keyword cloud information.
  10 in total

1.  Lab work goes social, and vice versa: strategising public engagement processes : commentary on: "What happens in the lab does not stay in the lab: applying midstream modulation to enhance critical reflection in the laboratory".

Authors:  Brian Wynne
Journal:  Sci Eng Ethics       Date:  2011-10-21       Impact factor: 3.525

2.  Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.

Authors:  Panga Jaipal Reddy; Rekha Jain; Young-Ki Paik; Robin Downey; Adam S Ptolemy; Vural Ozdemir; Sanjeeva Srivastava
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-03-01

3.  End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.

Authors:  Vural Ozdemir; Erik Fisher; Edward S Dove; Hilary Burton; Galen E B Wright; Mario Masellis; Louise Warnich
Journal:  Curr Pharmacogenomics Person Med       Date:  2012-01-01

4.  Evidence to action in the developing world: what evidence is needed?

Authors:  Tikki Pang
Journal:  Bull World Health Organ       Date:  2007-04       Impact factor: 9.408

5.  'Regular science' is inherently political.

Authors:  Edward S Dove; Vural Ozdemir
Journal:  EMBO Rep       Date:  2012-12-21       Impact factor: 8.807

6.  Theranostics, the 21st century bioeconomy and 'one health'. Interview by Tikki Pang.

Authors:  Vural Özdemir; Edward S Dove
Journal:  Expert Rev Mol Diagn       Date:  2012-11       Impact factor: 5.225

7.  Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).

Authors:  Vural Ozdemir; David S Rosenblatt; Louise Warnich; Sanjeeva Srivastava; Ghazi O Tadmouri; Ramy K Aziz; Panga Jaipal Reddy; Aresha Manamperi; Edward S Dove; Yann Joly; Ma'n H Zawati; Candan Hızel; Yasemin Yazan; Leela John; Emmanuelle Vaast; Adam S Ptolemy; Samer A Faraj; Eugene Kolker; Richard G H Cotton
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12-01

8.  Genomic sovereignty and the African promise: mining the African genome for the benefit of Africa.

Authors:  Jantina de Vries; Michael Pepper
Journal:  J Med Ethics       Date:  2012-04-06       Impact factor: 2.903

9.  Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action.

Authors:  Edward S Dove; Samer A Faraj; Eugene Kolker; Vural Ozdemir
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

10.  Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.

Authors:  Louise Warnich; Britt I Drögemöller; Michael S Pepper; Collet Dandara; Galen E B Wright
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09
  10 in total
  4 in total

1.  Bernard Lerer: recipient of the 2014 inaugural Werner Kalow Responsible Innovation Prize in Global Omics and Personalized Medicine (Pacific Rim Association for Clinical Pharmacogenetics).

Authors:  Vural Ozdemir; Laszlo Endrenyi; Sükrü Aynacıoğlu; Nicola Luigi Bragazzi; Collet Dandara; Edward S Dove; Lynnette R Ferguson; Christy Jo Geraci; Ernst Hafen; Belgin Eroğlu Kesim; Eugene Kolker; Edmund J D Lee; Adrian Llerena; Muradiye Nacak; Kazutaka Shimoda; Toshiyuki Someya; Sanjeeva Srivastava; Brian Tomlinson; Effy Vayena; Louise Warnich; Umit Yaşar
Journal:  OMICS       Date:  2014-03-20

2.  All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.

Authors:  Edward S Dove; Vural Ozdemir
Journal:  Per Med       Date:  2013-05-01       Impact factor: 2.512

3.  A Mobilising Concept? Unpacking Academic Representations of Responsible Research and Innovation.

Authors:  Barbara E Ribeiro; Robert D J Smith; Kate Millar
Journal:  Sci Eng Ethics       Date:  2016-03-08       Impact factor: 3.525

4.  Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics.

Authors:  Nicola Luigi Bragazzi
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.